Phibro Current Deferred Revenue from 2010 to 2024
| PAHC Stock | USD 24.14 0.40 1.68% |
Current Deferred Revenue | First Reported 2006-03-31 | Previous Quarter 5.3 M | Current Value 2.9 M | Quarterly Volatility 18.5 M |
Check Phibro Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phibro Animal's main balance sheet or income statement drivers, such as Depreciation And Amortization of 38 M, Interest Expense of 18.1 M or Selling General Administrative of 139.2 M, as well as many indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.0277 or PTB Ratio of 3.21. Phibro financial statements analysis is a perfect complement when working with Phibro Animal Valuation or Volatility modules.
Phibro | Current Deferred Revenue |
Latest Phibro Animal's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Phibro Animal Health over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Phibro Animal's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phibro Animal's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Phibro Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 31,223,990 | |
| Geometric Mean | 21,492,440 | |
| Coefficient Of Variation | 58.64 | |
| Mean Deviation | 13,624,409 | |
| Median | 30,830,000 | |
| Standard Deviation | 18,309,363 | |
| Sample Variance | 335.2T | |
| Range | 58.1M | |
| R-Value | (0.14) | |
| Mean Square Error | 353.7T | |
| R-Squared | 0.02 | |
| Significance | 0.61 | |
| Slope | (583,511) | |
| Total Sum of Squares | 4693.3T |
Phibro Current Deferred Revenue History
About Phibro Animal Financial Statements
Phibro Animal stakeholders use historical fundamental indicators, such as Phibro Animal's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Phibro Animal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Phibro Animal's assets and liabilities are reflected in the revenues and expenses on Phibro Animal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Phibro Animal Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 10.2 M | 9.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out the analysis of Phibro Animal Correlation against competitors. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 0.48 | Earnings Share 0.43 | Revenue Per Share 25.843 | Quarterly Revenue Growth 0.126 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.